Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15K Sell
51
-176
-78% -$4.92K ﹤0.01% 2244
2026
Q1
$8.31K Sell
227
-24
-10% -$947 ﹤0.01% 1919
2025
Q4
$11.4K Buy
251
+36
+17% +$1.6K ﹤0.01% 1774
2025
Q3
$9.1K Buy
215
+28
+15% +$1.05K ﹤0.01% 1711
2025
Q2
$5.82K Buy
187
+91
+95% +$2.46K ﹤0.01% 1785
2025
Q1
$2.36K Hold
96
﹤0.01% 1941
2024
Q4
$2.75K Hold
96
﹤0.01% 1871
2024
Q3
$2.56K Buy
96
+53
+123% +$1.38K ﹤0.01% 1925
2024
Q2
$1.1K Buy
43
+31
+258% +$695 ﹤0.01% 1952
2024
Q1
$254 Buy
+12
New +$223 ﹤0.01% 2114

Other funds holding AORT

UMB Bank's AORT Position: Q2 2026 in Review

UMB Bank reduced its Artivion (AORT) stake by 78% in Q2 2026, selling an estimated $4.92K and leaving 51 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2244.

UMB Bank first reported a position in AORT in Q1 2024 and has held it in 10 quarters since. The position peaked at $11.4K in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • UMB Bank held 51 shares of Artivion worth $1.15K as of Q2 2026.
  • UMB Bank sold 176 Artivion shares in Q2 2026, an estimated $4.92K.
  • Artivion made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #2244 holding.
  • UMB Bank first reported a position in Artivion in Q1 2024 and has held it in 10 quarters since.
  • UMB Bank's Artivion position peaked at $11.4K in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.